Executive Director, Clinical Development - Oncology & ADCs

Sutro Biopharma, Inc.; South San Francisco (CA); On-site; USD 350,000 - 500,000; Full time

Job summary

Sutro Biopharma, Inc. is seeking an Executive Director, Clinical Development to partner with the VP to shape the clinical strategy for its oncology portfolio. The role focuses on safety assessment, study leadership, and early development programs, with emphasis on ADCs and targeted therapies.

Travel to sites worldwide is expected. Ideal candidates are physician-scientists with deep oncology expertise, strong regulatory and medical monitoring experience, and a track record of translating clinical

Qualifications

• MD or MD/PhD required with substantial oncology clinical development experience.
• Over 10 years of clinical research and drug development experience in biotech/pharma.
• Strong clinical safety background including medical monitoring and signal assessment.
• Experience leading interventional clinical studies and global trials across countries.
• Deep knowledge of early clinical development including first-in-human studies and expansion cohorts.
• Ability to communicate complex data to senior leaders and regulatory bodies.

Responsibilities

• Lead clinical strategy and study leadership across oncology programs.
• Collaborate with global study leads to refine development plans and endpoints.
• Oversee safety monitoring and pharmacovigilance collaboration.
• Support regulatory content for submissions and health authority interactions.
• Engage with investigators and advisory boards to translate insights into development options.
• Collaborate across functions to align on questions and decisions.

Skills

Oncology clinical development

Medical monitoring

Regulatory knowledge

Scientific communication

Leadership

Travel internationally

Education

MD or MD/PhD

Job description

Sutro Biopharma, Inc. is seeking an Executive Director, Clinical Development to partner with the VP to shape the clinical strategy for its oncology portfolio. The role focuses on safety assessment, study leadership, and early development programs, with emphasis on ADCs and targeted therapies.

Travel to sites worldwide is expected. Ideal candidates are physician-scientists with deep oncology expertise, strong regulatory and medical monitoring experience, and a track record of translating clinical